Variant report
Variant | nsv1040274 |
---|---|
Chromosome Location | chr10:54929854-54964636 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr10:54961525..54963201-chr10:54972554..54974128,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs149514077 | chr10:54934000-54934001 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs544105957 | chr10:54934001-54934002 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs563782371 | chr10:54934068-54934069 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs75709135 | chr10:54934090-54934091 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs372449845 | chr10:54934098-54934099 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs372735558 | chr10:54934110-54934111 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs12249831 | chr10:54934122-54934123 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs78886051 | chr10:54934125-54934126 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs77836553 | chr10:54934144-54934145 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs372987453 | chr10:54934205-54934206 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs369275020 | chr10:54934240-54934241 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs530877722 | chr10:54934262-54934263 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs550074440 | chr10:54934272-54934273 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs569819438 | chr10:54934304-54934305 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs114205883 | chr10:54934313-54934314 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs375168325 | chr10:54934331-54934332 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs147185272 | chr10:54934342-54934343 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs555251895 | chr10:54934363-54934364 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs565485875 | chr10:54934394-54934395 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs189455030 | chr10:54935002-54935003 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs181445132 | chr10:54935027-54935028 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs530953923 | chr10:54935043-54935044 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs7900439 | chr10:54935107-54935108 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs11003440 | chr10:54935109-54935110 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs79132799 | chr10:54935131-54935132 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs537019806 | chr10:54935166-54935167 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs559249319 | chr10:54936826-54936827 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs532958147 | chr10:54936851-54936852 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs373670353 | chr10:54936878-54936879 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs528367164 | chr10:54936906-54936907 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs544843345 | chr10:54936920-54936921 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs142503285 | chr10:54936937-54936938 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs377297534 | chr10:54936941-54936942 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs112582324 | chr10:54937000-54937001 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs34868951 | chr10:54937025-54937026 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs150962252 | chr10:54937029-54937030 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs182110292 | chr10:54937052-54937053 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs68049516 | chr10:54937086-54937087 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs140763523 | chr10:54937098-54937099 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs186887546 | chr10:54937106-54937107 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs200921871 | chr10:54937126-54937127 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs202229904 | chr10:54937127-54937128 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs397742303 | chr10:54937128-54937129 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs199557417 | chr10:54937129-54937130 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs546601128 | chr10:54937142-54937143 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs73352793 | chr10:54937206-54937207 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs192589423 | chr10:54937216-54937217 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs200289981 | chr10:54937235-54937236 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs374640752 | chr10:54937296-54937297 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs559255566 | chr10:54937318-54937319 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 18414403 | CNVD |
Cockayne syndrome | 18421352 | CNVD |
Glioblastoma | 16823260 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neuroblastoma | 17533364 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Glioma | 21971842 | CNVD |
Cancer | 21637783 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Obesity | 21956041 | CNVD |
Developmental delay | 21948486 | CNVD |
Dysmorphic features | 21948486 | CNVD |
Epilepsy | 21948486 | CNVD |
Intellectual disability | 21948486 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Autism | 20841430 | CNVD |
Mental retardation | 17124404 | CNVD |
Epilepsy | 20923578 | CNVD |
Prostate cancer | 16573809 | CNVD |
Schizophrenia | 19329560 | CNVD |
Heart failure | 18772530 | CNVD |
Heart failure | 18854381 | CNVD |
Hyperglycemia | 19060297 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Usher syndrome | 20538994 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autism | 20858243 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:54934000-54934400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
2 | chr10:54934000-54934400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
3 | chr10:54935000-54935200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr10:54936800-54938000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
5 | chr10:54951400-54951600 | Active TSS | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr10:54951600-54960800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
7 | chr10:54960800-54961200 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
8 | chr10:54961200-54965000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
9 | chr10:54964200-54966000 | ZNF genes & repeats | HUES64 Cell Line | embryonic stem cell |